{"title": "Clinical Data on Hospital Environmental Hygiene Monitoring and Medical Staff Protection during the Coronavirus Disease 2019 Outbreak", "doi": "10.1101/2020.02.25.20028043", "citation_id": "2020.02.25.20028043v2", "date": "2020-03-02", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.25.20028043", "abstract": "<p>Background: The outbreak of coronavirus disease 2019 (COVID-19) has placed unprecedented challenges on hospital environmental hygiene and medical staff protection. It is crucial to assess hospital environmental hygiene to understand the most important environmental issues for controlling the spread of COVID-19 in hospitals. \nObjective: To detect the presence of COVID-19 in the samples from the area at risk of contamination in the First Hospital of Jilin University.\nMethods: Viruses in the air were collected by natural sedimentation and air particle sampler methods. Predetermined environmental surfaces were sampled using swabs at seven o9clock in the morning before disinfection. The real-time reverse-transcription PCR method was used to detect the existence of COVID-19 pathogens.\nResults: Viruses could be detected on the surfaces of the nurse station in the isolation area with suspected patients and in the air of the isolation ward with an intensive care patient.\nConclusion: Comprehensive monitoring of hospital environmental hygiene during pandemic outbreaks is conducive to the refinement of hospital infection control. It is of great significance to ensure the safety of medical treatment and the quality of hospital infection control through the monitoring of environmental hygiene.</p>", "twitter_description": "Background: The outbreak of coronavirus disease 2019 (COVID-19) has placed unprecedented challenges on hospital environmental hygiene and medical staff protection. It is crucial to assess hospital environmental hygiene to understand the most important environmental issues for controlling the spread of COVID-19 in hospitals. Objective: To detect the presence of COVID-19 in the samples from the area at risk of contamination in the First Hospital of Jilin University. Methods: Viruses in the air were collected by natural sedimentation and air particle sampler methods. Predetermined environmental surfaces were sampled using swabs at seven o'clock in the morning before disinfection. The real-time reverse-transcription PCR method was used to detect the existence of COVID-19 pathogens. Results: Viruses could be detected on the surfaces of the nurse station in the isolation area with suspected patients and in the air of the isolation ward with an intensive care patient. Conclusion: Comprehensive monitoring of hospital environmental hygiene during pandemic outbreaks is conducive to the refinement of hospital infection control. It is of great significance to ensure the safety of medical treatment and the quality of hospital infection control through the monitoring of environmental hygiene.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nthe National Natural Science Foundation of China (Nos. 30972610 and 81273240), Jilin Province Science and Technology Agency (Nos. 20160101037JC, 20170622009JC, 2017C021, and 2017J039), Norman Bethune Program of Jilin University (2012206), and Open Project Funding from State Key Laboratory of Kidney Diseases.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll data, models, and code generated or used during the study appear in the submitted article.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.25.20028043v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.25.20028043v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.25.20028043v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/02/2020.02.25.20028043.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.25.20028043v2", "access_rights": "restricted", "authors": ["Yanfang Jiang", "Haifeng Wang", "Yukun Chen", "Jiaxue He", "Liguo Chen", "Yong Liu", "Xinyuan Hu", "Ang Li", "Siwen Liu", "Peng Zhang", "Hongyan Zou", "Shucheng Hua"]}